EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
31 hedge funds and large institutions have $257M invested in ESSA Pharma in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
14% less funds holding
Funds holding: 36 → 31 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
31
Holding in Top 10
1
Calls
$360K
Puts
$161K
Top Buyers
| 1 | +$27.7M | |
| 2 | +$15.2M | |
| 3 | +$7.13M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$616K |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$2.6M | |
| 3 | -$1.46M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$296K |
| 5 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$261K |